CA2340794A1 - Molecules associees au transport de proteines - Google Patents

Molecules associees au transport de proteines Download PDF

Info

Publication number
CA2340794A1
CA2340794A1 CA002340794A CA2340794A CA2340794A1 CA 2340794 A1 CA2340794 A1 CA 2340794A1 CA 002340794 A CA002340794 A CA 002340794A CA 2340794 A CA2340794 A CA 2340794A CA 2340794 A1 CA2340794 A1 CA 2340794A1
Authority
CA
Canada
Prior art keywords
leu
ptam
glu
ser
polynucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002340794A
Other languages
English (en)
Inventor
Y. Tom Tang
Preeti Lal
Olga Bandman
Henry Yue
Neil C. Corley
Karl J. Guegler
Gina A. Gorgone
Mariah R. Baughn
Chandra Patterson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2340794A1 publication Critical patent/CA2340794A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

L'invention concerne des molécules de transport de protéines (PTAM) humaines et des polynucléotides qui identifient et codent pour PTAM. L'invention concerne également des vecteurs d'expression, des cellules hôtes, des anticorps, des agonistes et des antagonistes. L'invention concerne en outre des procédés utiles pour diagnostiquer, traiter ou prévenir des troubles associés à l'expression de PTAM.
CA002340794A 1998-08-27 1999-08-26 Molecules associees au transport de proteines Abandoned CA2340794A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9820698P 1998-08-27 1998-08-27
US60/098,206 1998-08-27
PCT/US1999/019616 WO2000012703A2 (fr) 1998-08-27 1999-08-26 Molecules associees au transport de proteines

Publications (1)

Publication Number Publication Date
CA2340794A1 true CA2340794A1 (fr) 2000-03-09

Family

ID=22267998

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002340794A Abandoned CA2340794A1 (fr) 1998-08-27 1999-08-26 Molecules associees au transport de proteines

Country Status (5)

Country Link
EP (1) EP1108019A2 (fr)
JP (1) JP2002523089A (fr)
AU (1) AU5587799A (fr)
CA (1) CA2340794A1 (fr)
WO (1) WO2000012703A2 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8007798B2 (en) 1997-11-21 2011-08-30 Genentech, Inc. Treatment of complement-associated disorders
US7192589B2 (en) 1998-09-16 2007-03-20 Genentech, Inc. Treatment of inflammatory disorders with STIgMA immunoadhesins
US7419663B2 (en) 1998-03-20 2008-09-02 Genentech, Inc. Treatment of complement-associated disorders
US8088386B2 (en) 1998-03-20 2012-01-03 Genentech, Inc. Treatment of complement-associated disorders
CA2410679A1 (fr) * 2000-06-29 2002-01-10 Incyte Genomics, Inc. Molecules de circulation et de secretion
JP2003259872A (ja) * 2002-03-07 2003-09-16 Japan Science & Technology Corp ヒト食道癌抗原ペプチドと食道癌診断方法
PT2500030E (pt) 2005-11-04 2015-09-24 Genentech Inc Uso de inibidores da via do complemento para tratar doenças oculares
US7776573B2 (en) 2006-06-01 2010-08-17 Genentech, Inc. Crystal structure of CRIg and C3b:CRIg complex
WO2008036135A2 (fr) * 2006-06-01 2008-03-27 Genentech, Inc. STRUCTURE CRISTALLINE DE CRIg ET D'UN COMPLEXE C3b:CRIg
PL2907827T3 (pl) 2006-11-02 2019-03-29 Genentech, Inc. Humanizowane przeciwciała przeciw czynnikowi D i ich zastosowanie
AR066660A1 (es) 2007-05-23 2009-09-02 Genentech Inc Prevencion y tratamiento de condiciones del ojo asociadas con su complemento
CR20170001A (es) 2008-04-28 2017-08-10 Genentech Inc Anticuerpos anti factor d humanizados
WO2009137605A2 (fr) 2008-05-06 2009-11-12 Genentech, Inc. Variants de crig à maturation d'affinité
CR20160132A (es) 2013-08-12 2016-08-25 Genentech Inc Composiciones y método para tratar condiciones asociadas con el complemento
KR20160147855A (ko) 2014-05-01 2016-12-23 제넨테크, 인크. 항-인자 d 항체 변이체 및 이의 용도
HK1257422A1 (zh) 2015-10-30 2019-10-18 豪夫迈‧罗氏有限公司 抗-因子d抗体变体缀合物及其用途
EP3368074A2 (fr) 2015-10-30 2018-09-05 Hoffmann-La Roche AG Anticorps et conjugués anti-facteur d

Also Published As

Publication number Publication date
WO2000012703A3 (fr) 2000-06-22
WO2000012703A2 (fr) 2000-03-09
EP1108019A2 (fr) 2001-06-20
JP2002523089A (ja) 2002-07-30
AU5587799A (en) 2000-03-21

Similar Documents

Publication Publication Date Title
US20010010913A1 (en) Extracellular adhesive proteins
JP2002543785A (ja) 細胞外マトリックス及び接着関連タンパク質
US5989863A (en) Human ankyrin family protein
WO2000012703A2 (fr) Molecules associees au transport de proteines
CA2335653A1 (fr) Molecules associees a une proliferation cellulaire
CA2342301A1 (fr) Proteine pdz humaine de jonction de cellule
US6077693A (en) Polynucleotide encoding a promonocyte associated protein
EP1173566A2 (fr) Proteines humaines associees aux membranes
CA2332309A1 (fr) Proteines associees a la neurotransmission
CA2333467A1 (fr) Proteine humaine associee a la preseniline
CA2349814A1 (fr) Regulateurs de signaux de la cytokine
CA2340277A1 (fr) Proteines humaines associees a l'arn
US5962263A (en) Human membrane recycling proteins
CA2332379A1 (fr) Molecules associees a l'apoptose
WO2000011164A1 (fr) Angiopoietine-3 humaine
CA2363009A1 (fr) Proteines associees aux leucocytes et au systeme sanguin
CA2347650A1 (fr) Proteines transmembranaires 4
WO2000018924A1 (fr) Petite molecule humaine riche en proline
CA2335228A1 (fr) Proteines epidermiques humaines hepi-1 a hepi-6
WO1999064593A2 (fr) Proteines de regulation du cycle cellulaire
EP1058730A1 (fr) Glycoproteines liees aux synapses humaines
EP1121430A1 (fr) Proteine de liaison isre humaine
EP1531161A2 (fr) Protéines épidermiques humaines Hepi-1 à Hepi-6
CA2355074A1 (fr) Proteines membranaires lymphocytaires
CA2348046A1 (fr) Proteine statherine riche en lysine

Legal Events

Date Code Title Description
FZDE Dead